Table 2.
Clinicopathological Features in Breast Cancer Patients
| Parameters | Non-Familial Breast Cancer N= 50 (%) |
Familial Breast Cancer N=30 (%) |
p-value |
|---|---|---|---|
| Age (years) | 0.16 | ||
| <45 | 16 (32.0) | 14 (46.7) | |
| ≥45 | 34 (68.0) | 16 (53.3) | |
| Tumor Size (Mean±SD) | 5.7±3.9 | 4.3±2.6 | 0.031 |
| ER-status | 0.036 | ||
| Positive | 42 (84) | 19 (63.3) | |
| Negative | 8 (16) | 11 (36.7) | |
| PR-Status | |||
| Positive | 37 (74) | 20 (66.7) | 0.48 |
| Negative | 13 (26) | 10 (33.3) | |
| Lymph Node Involvement | |||
| Positive | 38 (76) | 24 (80) | 0.67 |
| Negative | 12 (24) | 6 (20) | |
| Safety Margin | |||
| Positive | 4 (8) | 3 (10) | 0.75 |
| Negative | 46 (92) | 27 (90) | |
| Tumor Grade | |||
| G I, II | 45 (90) | 27 (90) | 1.00 |
| G III | 5 (10) | 3 (10) | |
| Pathological Type | |||
| Invasive duct carcinoma | 46 (92) | 26 (86.7) | 0.44 |
| Invasive lobular carcinoma | 4 (8) | 4 (13.3) | |
| Menopausal Status | |||
| Premenopausal | 21 (42) | 20 (66.7) | 0.033 |
| Postmenopausal | 29 (58) | 10 (33.3) | |
| Laterality | |||
| Right | 31 (63.3) | 15 (50) | 0.25 |
| Left | 18 (36.7) | 15 (50) | |
| Stage | |||
| II | 25 (50) | 19 (63.3) | 0.54 |
| III | 21 (42) | 10 (33.3) | |
| IV | 4 (8) | 1 (3.3) | |
| Hormonal Therapy | 0.119 | ||
| Yes | 41 (82) | 20 (66.7) | |
| No | 9 (18) | 10 (33.3) |